Chang Wei Terk, Kowalski Stefan R, Sorich Wassana, Alderman Christopher P
Pharmacy Department, Ng Teng Fong General Hospital, Singapore, Singapore.
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.
Int J Clin Pharm. 2017 Aug;39(4):867-873. doi: 10.1007/s11096-017-0490-y. Epub 2017 May 26.
Background There is a relative paucity of information to characterise potential changes in medication regimen complexity and prevalence of prescribing of potentially inappropriate medications after hospitalisation, both in Australia and elsewhere. Objective To evaluate medication regimen complexity and the prevalence of potentially inappropriate medications before and after admission to hospital. Setting General medical units of a tertiary care hospital in Australia. Methods Retrospective cohort study of patients aged 65 years and above. Medication complexity was measured by using the Medication Regimen Complexity Index (MRCI). Main outcome measure The primary outcome was the change in the Medication Regimen Complexity Index for all prescribed medications after hospitalization. Results A convenience sample of 100 patients was included in the study. There was a significant change in the mean medication complexity score (as measured using the MRCI), increasing from 29 at the time of admission to 32 at the time of discharge (p < 0.05). Factors such as baseline medication regimen complexity (pre-admission MRCI) and length of stay in the hospitals appear to influence the change in medication complexity. However, the proportion of patients prescribed at least one potentially inappropriate medicine (PIM) decreased significantly, from 52% pre-hospitalization to 42% at discharge (p = 0.04). Conclusions Relative to the time of admission, overall medication complexity increased and the proportion of patients who were prescribed PIMs decreased after hospitalisation.
在澳大利亚和其他地方,关于住院后药物治疗方案复杂性的潜在变化以及开具潜在不适当药物的患病率的信息相对较少。
评估入院前后的药物治疗方案复杂性和潜在不适当药物的患病率。
澳大利亚一家三级护理医院的普通内科病房。
对65岁及以上患者进行回顾性队列研究。使用药物治疗方案复杂性指数(MRCI)来衡量药物复杂性。
主要结局是住院后所有处方药物的药物治疗方案复杂性指数的变化。
该研究纳入了100名患者的便利样本。平均药物复杂性评分有显著变化(使用MRCI测量),从入院时的29分增加到出院时的32分(p < 0.05)。诸如基线药物治疗方案复杂性(入院前MRCI)和住院时间等因素似乎会影响药物复杂性的变化。然而,开具至少一种潜在不适当药物(PIM)的患者比例显著下降,从住院前的52%降至出院时的42%(p = 0.04)。
相对于入院时,住院后总体药物复杂性增加,开具PIMs的患者比例下降。